Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 
China Opens Door to Stronger U.S. Trade Ties Amid Rising Tensions 
Valero Port Arthur Refinery Explosion Prompts $1M Lawsuit Over Worker Safety Negligence 
SpaceX IPO Filing Expected This Week as Valuation Could Surpass $75 Billion 
Currency Markets Show Caution Amid U.S.-Iran Negotiations 
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s 
Novo Nordisk Shares Tumble After CagriSema Misses Key Trial Endpoint 
Australia's Inflation Eases in February but Core Pressures Persist 
Is dark chocolate healthier than milk chocolate? 2 dietitians explain 
Lynas Rare Earths Signs Vietnam Deal with LS Eco Energy to Boost Magnet Metal Production 
WTO Reform Talks Begin in Cameroon Amid Global Trade Tensions 
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market 
Middle East War Rattles Global Markets as Oil Tops $100 and Dollar Surges 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Asian Currencies Stay Muted as Dollar Holds Firm Amid Iran Uncertainty 
Iran Allows Oil Tankers Through Strait of Hormuz Amid U.S. Negotiations 
Google's TurboQuant Algorithm Sends Memory Chip Stocks Tumbling 
The World Bank lowered its China growth forecast for the year from 4.3 percent predicted in June to 2.7 percent due to the impact of the pandemic and property sector weaknesses on its economy.
The institution also slashed its forecast for next year from 8.1 percent down to 4.3 percent.
Many analysts believe that China's GDP growth target of around 5.5 percent for the year is now unattainable.
According to the World Bank, outbreaks and growth slowdowns in China have been followed by uneven recoveries.
Disruption to businesses has continued in China as cases surge and some restrictions remain in place.
Health officials have acknowledged that since bulk testing criteria were removed, official data no longer accurately reflect domestic infections.
The IMF forewarned last week that it will likely also reduce its predictions for China, blaming a sustained rise in cases.
The fund revised its growth forecast for China in October, lowering it to 3.2 percent this year, the lowest level in decades from the 4.4 percent it expected the previous year.
According to IMF chief Kristalina Georgieva, they are very likely to downgrade the growth projections for China, both for 2022 and 2023,
As China moves forward with the reopening, experts worry that it is ill-prepared to handle the next wave of diseases since millions of susceptible elderly people have not yet had all of the recommended vaccinations.
